Acquisition adds high-payload herpes simplex virus (HSV) gene therapy targeting genetic skin diseases to LEO Pharma’s ...

Dermatologists are disproportionately located at high rates in urban areas and low rates in rural areas — a reality driven by ...

When it comes to identifying skin conditions, AI may increase a patient’s accuracy and confidence, according to a study ...

Findings support the Timed Up and Go (TUG) test combined with pain assessment as a promising functional endpoint for evaluating mobility impairment in palmoplantar epidermal differentiation disorders ...

While it was previously thought that keratinocytes (skin cells) were only passive conductors that allow the rabies virus to ...

Landmark 10th Annual Awards Program Recognizes the Most Innovative Digital Health and Medical Technology Solutions Worldwide ...

April 30 (Reuters) - Danish drugmaker LEO Pharma said on Thursday it had agreed to buy U.S. drug developer Replay for $50 million upfront, adding an experimental treatment platform for rare genetic ...

LEO Pharma has announces that it will acquire Replay, a gene therapy company focused on developing transformative treatments ...

Repeated skin flare-ups are not random. Experts explain these indicate deeper body imbalances. Conditions like acne and ...

Evotec SE, a life science company that is pioneering the future of drug discovery and development, announced the nomination of a small molecule preclinical development candidate (PDC) from its ...

The saying "cold hands, warm heart" is usually meant metaphorically—but new research from UC Davis School of Medicine and ...